The Bevacizumab Experience in Advanced Renal Cell Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s8157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2015English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Clinical Experience and Critical Evaluation of the Role of Everolimus in Advanced Renal Cell Carcinoma

Research and Reports in Urology
Urology
2011English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Management of Locally Advanced Renal Cell Carcinoma

Cancer Control
MedicineOncologyHematology
2006English

Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma

European Urology
Urology
2016English

Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy